Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Impaired Autophagy in the Lipid-Storage Disorder Niemann-Pick Type C1 Disease

Impaired Autophagy in the Lipid-Storage Disorder Niemann-Pick Type C1 Disease

Thumbnail Image
Download
Name

Sarkar-2013-Impaired Autophagy i.pdf

Size

3.46 MB

Format

Adobe PDF

Checksum (MD5)

d90bcaaf5d005651f110f4e089b5b54b

Author(s)
Sarkar, Sovan
•
Carroll, Bernadette
•
Buganim, Yosef
•
Maetzel, Dorothea
•
Ng, Alex H. M.
•
Cassady, John P.
•
Cohen, Malkiel A.
•
Chakraborty, Souvik
•
Wang, Haoyi
•
Spooner, Eric
more
Date Issued
November 2013
Journal
Cell Reports
Publisher
Elsevier
Citation
Sarkar, Sovan, Bernadette Carroll, Yosef Buganim, Dorothea Maetzel, Alex H.M. Ng, John P. Cassady, Malkiel A. Cohen, et al. “Impaired Autophagy in the Lipid-Storage Disorder Niemann-Pick Type C1 Disease.” Cell Reports 5, no. 5 (December 2013): 1302–1315.
Version
Final published version
Abstract
Autophagy dysfunction has been implicated in misfolded protein accumulation and cellular toxicity in several diseases. Whether alterations in autophagy also contribute to the pathology of lipid-storage disorders is not clear. Here, we show defective autophagy in Niemann-Pick type C1 (NPC1) disease associated with cholesterol accumulation, where the maturation of autophagosomes is impaired because of defective amphisome formation caused by failure in SNARE machinery, whereas the lysosomal proteolytic function remains unaffected. Expression of functional NPC1 protein rescues this defect. Inhibition of autophagy also causes cholesterol accumulation. Compromised autophagy was seen in disease-affected organs of Npc1 mutant mice. Of potential therapeutic relevance is that HP-β-cyclodextrin, which is used for cholesterol-depletion treatment, impedes autophagy, whereas stimulating autophagy restores its function independent of amphisome formation. Our data suggest that a low dose of HP-β-cyclodextrin that does not perturb autophagy, coupled with an autophagy inducer, may provide a rational treatment strategy for NPC1 disease.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Whitehead Institute for Biomedical Research
Terms of Use
Creative Commons Attribution
http://creativecommons.org/licenses/by-nc-nd/3.0/
Persistent DSpace Link
http://hdl.handle.net/1721.1/90306
DOI of Published Version
https://doi.org/10.1016/j.celrep.2013.10.042
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.